Global Orthopaedic Bone Cement Market Insights and Forecast to 2028

Market Analysis and Insights: Global Orthopaedic Bone Cement Market
Due to the COVID-19 pandemic, the global Orthopaedic Bone Cement market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Low Viscosity Cements accounting for % of the Orthopaedic Bone Cement global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Orthopaedic Bone Cement market size is valued at US$ million in 2021, while the US and Europe Orthopaedic Bone Cement are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Orthopaedic Bone Cement landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Orthopaedic Bone Cement include Stryker (US), Zimmer Biomet (US), DePuy Synthes (Johnson & Johnson) (US), DJO (US), Smith & Nephew (US), Teknimed (FR), aap Implantate AG (DE), Tecres (IT) and Medacta (CH), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Orthopaedic Bone Cement Scope and Segment
Orthopaedic Bone Cement market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Orthopaedic Bone Cement market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Low Viscosity Cements
Medium Viscosity Cements
High Viscosity Cements
Segment by Application
Hospitals
Ambulatory Surgical Centres
Orthopaedic Clinics
By Company
Stryker (US)
Zimmer Biomet (US)
DePuy Synthes (Johnson & Johnson) (US)
DJO (US)
Smith & Nephew (US)
Teknimed (FR)
aap Implantate AG (DE)
Tecres (IT)
Medacta (CH)
Osseon (US)
G-21 (IT)
Cook Medical (US)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E